New hope for liver cancer: pfizer tests experimental drug

NCT ID NCT07227012

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a new drug called PF-08634404, given alone or with another drug (ipilimumab), in adults with advanced liver cancer that cannot be surgically removed. The goal is to check safety, side effects, and whether the drug shrinks tumors. About 138 participants will receive the treatment through IV infusions at clinical trial sites.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

PF-08634404 (a biologic drug) and ipilimumab (also known as Yervoy)

What this could lead to

If successful, this could lead to a new treatment option for people with advanced liver cancer that cannot be removed by surgery.

What could go wrong

This is an early-phase trial (Phase 1b/2) with a small number of participants, so the drug may not prove effective or safe enough for wider use. Side effects are possible, and the combination with ipilimumab may increase risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma liver and intrahepatic bile duct neoplasm Liver Neoplasms pediatric hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Cancer Center

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Allina Health Cancer Institute - Abbott Northwestern Hospital

    RECRUITING

    Minneapolis, Minnesota, 55407, United States

  • Allina Health Cancer Institute - Mercy Hospital

    RECRUITING

    Coon Rapids, Minnesota, 55433, United States

  • Allina Health Cancer Institute - United Hospital

    RECRUITING

    Saint Paul, Minnesota, 55102, United States

  • Barnes-Jewish Hospital

    NOT_YET_RECRUITING

    St Louis, Missouri, 63110, United States

  • Kindai University Hospital- Osaka Medical Campus

    RECRUITING

    Sakai, Osaka, 590-0197, Japan

  • Memorial Hospital

    NOT_YET_RECRUITING

    Shiloh, Illinois, 62269, United States

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • Moffitt Cancer Center - International Plaza

    RECRUITING

    Tampa, Florida, 33607, United States

  • Moffitt Cancer Center - McKinley Campus

    RECRUITING

    Tampa, Florida, 33612, United States

  • Moffitt Cancer Center at SouthShore

    RECRUITING

    Ruskin, Florida, 33570, United States

  • Moffitt Cancer Center at Speros

    RECRUITING

    Land O' Lakes, Florida, 34638, United States

  • Moffitt Cancer Center at Wesley Chapel

    RECRUITING

    Wesley Chapel, Florida, 33544, United States

  • Moffitt McKinley Hospital

    RECRUITING

    Tampa, Florida, 33612, United States

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, Chiba, 277-8577, Japan

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, 704, Taiwan

  • National Hospital Organization Kyushu Cancer Center

    RECRUITING

    Fukuoka, 811-1395, Japan

  • National Taiwan University Hospital

    NOT_YET_RECRUITING

    Taipei, 10002, Taiwan

  • Pan American Center for Oncology Trials, LLC

    RECRUITING

    Rio Piedras, 00935, Puerto Rico

  • Pan American Center for Oncology Trials, LLC

    RECRUITING

    San Juan, 00909, Puerto Rico

  • Pan American Center for Oncology Trials, LLC - Dorado Office

    RECRUITING

    Dorado, United States of America, 00646, Puerto Rico

  • Pan American Center for Oncology Trials, LLC - Mayaguez Office

    RECRUITING

    Mayagüez, United States of America, 00680, Puerto Rico

  • Pan American Center for Oncology Trials, LLC - Ponce Office

    RECRUITING

    Ponce, United States of America, 00730, Puerto Rico

  • Renown Health Medical Oncology

    RECRUITING

    Reno, Nevada, 89502, United States

  • Renown Office of Clinical Research

    RECRUITING

    Reno, Nevada, 89502, United States

  • Renown Regional Medical Center

    RECRUITING

    Reno, Nevada, 89502, United States

  • Siteman Cancer Center

    NOT_YET_RECRUITING

    St Louis, Missouri, 63108, United States

  • Siteman Cancer Center - North County

    NOT_YET_RECRUITING

    Florissant, Missouri, 63031, United States

  • Siteman Cancer Center - Shiloh

    NOT_YET_RECRUITING

    Shiloh, Illinois, 62269, United States

  • Siteman Cancer Center - South County

    NOT_YET_RECRUITING

    St Louis, Missouri, 63129, United States

  • Siteman Cancer Center - St. Peters

    NOT_YET_RECRUITING

    City of Saint Peters, Missouri, 63376, United States

  • Siteman Cancer Center - West County

    NOT_YET_RECRUITING

    Creve Coeur, Missouri, 63141, United States

  • Taichung Veterans General Hospital

    NOT_YET_RECRUITING

    Taichung, 407, Taiwan

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, 112, Taiwan

  • Washington University School of Medicine - Siteman Cancer Center

    NOT_YET_RECRUITING

    St Louis, Missouri, 63110, United States